Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIOngoingAug 2, 2023Diclofenac Sodium Topical Solution USPDefective Delivery SystemAlembic Pharmaceuticals, Inc. · D-0941-2023Class IITerminatedAug 2, 2023Methylphenidate Hydrochloride TabletsPresence of Foreign Substance: Metal embedded in a tablet.Sun Pharmaceutical Industries Inc · D-0940-2023Class IIOngoingAug 2, 2023Oxacillin for InjectionLack of Assurance of SterilitySagent Pharmaceuticals · D-0937-2023Class IIOngoingAug 2, 2023Oxacillin for InjectionLack of Assurance of SterilitySagent Pharmaceuticals · D-0936-2023Class IIOngoingAug 2, 2023Oxacillin for InjectionLack of Assurance of SterilitySagent Pharmaceuticals · D-0935-2023Class IITerminatedJul 26, 2023Famotidine TabletsLabeling: Label Error on Declared Strength: some cartons labeled and containing 20 mg may have an external label placed on the side of the carton indicating strength as...Glenmark Therapeutics, Inc. · D-0939-2023Class IITerminatedJul 26, 2023Norepinephrine 32 mg per 250 mLLack of Assurance of SterilitySterRx, LLC · D-0934-2023Class IITerminatedJul 26, 2023Norepinephrine 16 mg per 250 mLLack of Assurance of SterilitySterRx, LLC · D-0933-2023Class IITerminatedJul 26, 2023Norepinephrine 8 mg per 250 mLLack of Assurance of SterilitySterRx, LLC · D-0932-2023Class IITerminatedJul 26, 2023Norepinephrine 4 mg per 250 mLLack of Assurance of SterilitySterRx, LLC · D-0931-2023Class IITerminatedJul 26, 2023Sodium Bicarbonate in 5% Dextrose InjectionLack of Assurance of SterilitySterRx, LLC · D-0930-2023Class IITerminatedJul 26, 2023Vancomycin HCl 1.5 g added to 0.9% Sodium Chloride 500 mLCGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.New England Life Care, Inc. dba Advanced Compounding Solutions · D-0929-2023Class IITerminatedJul 26, 2023ROcuronium Bromide 50 mg/5 mLCGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.New England Life Care, Inc. dba Advanced Compounding Solutions · D-0928-2023Class IITerminatedJul 26, 2023PHENYLephrine HCl 10mg added to 0.9% Sodium Chloride 250mLCGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.New England Life Care, Inc. dba Advanced Compounding Solutions · D-0927-2023Class IITerminatedJul 26, 2023SUCCINYLcholine Chloride 200 mg/10mLCGMP Violations- that spaces adjacent to the production area may have been compromised at the time of production.New England Life Care, Inc. dba Advanced Compounding Solutions · D-0926-2023Class IIOngoingJul 26, 2023Fingolimod CapsulesFailed Dissolution SpecificationsAscend Laboratories, LLC · D-0925-2023Class IIITerminatedJul 26, 2023Loteprednol Etabonate Ophthalmic SuspensionSuperpotent Drug: Out of Specification (OOS) results observed for unit dose content.Sun Pharmaceutical Industries Inc · D-0924-2023Class IIOngoingJul 26, 2023Tizanidine Tablets USPFailed dissolution specification: Out of specification results observed in 24-month long term stability testing.Dr Reddy's Laboratories Limited · D-0923-2023Class ITerminatedJul 19, 2023Albuterol Sulfate Inhalation AerosolDefective container: empty inhaler and leakage observed through the inhaler valve due to partially missing bottom seat (gasket).Cipla USA, Inc. · D-0938-2023Class IIOngoingJul 19, 2023Delsam Pharma's ARTIFICIAL TEARSCGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as...Global Pharma Healthcare Private Limited · D-0922-2023Class IOngoingJul 19, 2023Delsam Pharma's ARTIFICIAL TEARSNon-Sterility: FDA analysis found unopened products to have bacterial contamination.Global Pharma Healthcare Private Limited · D-0921-2023Class IIOngoingJul 19, 2023Artificial TearsCGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as...Global Pharma Healthcare Private Limited · D-0920-2023Class IOngoingJul 19, 2023Artificial TearsNon-Sterility: FDA analysis found unopened products to have bacterial contamination.Global Pharma Healthcare Private Limited · D-0919-2023Class IITerminatedJul 19, 2023Bivalirudin for Injection 250 mgPresence of Particulate Matter: Particulate matter identified as fiber.Accord Healthcare, Inc. · D-0918-2023Class IITerminatedJul 19, 2023Atropine Sulfate InjectionPresence of Particulate Matter: Particulate matter identified as fiber.Accord Healthcare, Inc. · D-0917-2023Class IITerminatedJul 19, 20230.9% Sodium Chloride Injection USPLack of assurance of sterility: bags have the potential to leak.B. Braun Medical Inc. · D-0916-2023Class IIOngoingJul 19, 2023Big Machine Distillery Hand Sanitizer Non-Sterile Solution Alcohol Antiseptic 80% Topical SolutionCGMP Deviation: impurities exceed allowable limits.Tenn South Distillery LLC dba Big Machine Distillery · D-0915-2023Class IITerminatedJul 19, 2023Tiagabine Hydrochloride TabletsFailed Impurities: Out of Specification (OOS) result observed during Related Substances testingSun Pharmaceutical Industries Inc · D-0914-2023Class IITerminatedJul 19, 2023Sunitinib Malate CapsulesFailed Moisture Limits: Water (moisture) content above the approved product specifications.Teva Pharmaceuticals USA Inc · D-0913-2023Class IITerminatedJul 19, 2023Allergy ReliefFailed Impurities/Degradation SpecificationsL. Perrigo Company · D-0912-2023Class IITerminatedJul 19, 2023Picnic, Fexofenadine Hydrochloride TabletsFailed Impurities/Degradation SpecificationsL. Perrigo Company · D-0911-2023Class IITerminatedJul 19, 2023allergy reliefFailed Impurities/Degradation SpecificationsL. Perrigo Company · D-0910-2023Class IITerminatedJul 19, 2023allergyreliefFailed Impurities/Degradation SpecificationsL. Perrigo Company · D-0909-2023Class IITerminatedJul 19, 2023Fexofenadine Hydrochloride TabletsFailed Impurities/Degradation SpecificationsL. Perrigo Company · D-0908-2023Class IITerminatedJul 19, 2023Fexofenadine Hydrochloride TabletsFailed Impurities/Degradation SpecificationsL. Perrigo Company · D-0907-2023Class IITerminatedJul 19, 2023allergy reliefFailed Impurities/Degradation SpecificationsL. Perrigo Company · D-0906-2023Class IITerminatedJul 19, 2023Allergy ALLER-FEXFailed Impurities/Degradation SpecificationsL. Perrigo Company · D-0905-2023Class IITerminatedJul 19, 2023aller-easeFailed Impurities/Degradation SpecificationsL. Perrigo Company · D-0904-2023Class IITerminatedJul 19, 2023Allergy ReliefFailed Impurities/Degradation SpecificationsL. Perrigo Company · D-0903-2023Class IITerminatedJul 19, 2023Allergy ReliefFailed Impurities/Degradation SpecificationsL. Perrigo Company · D-0902-2023